Coronado Biosciences to Report Third Quarter 2012 Financial Results

[at noodls] – Conference Call Scheduled for November 14, 2012 Burlington, MA – November 7, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy … more

View todays social media effects on CNDO

View the latest stocks trending across Twitter. Click to view dashboard